AAFP: EHRs ‘suck the life out of everyone that uses them’

AAFP logo

A blog post from Shawn Martin, senior vice president of advocacy, practice advancement and policy at the American Academy of Family Physicians, argued the electronic health record (EHR) industry has failed to live up to promises to reduce costs, improve care and help avert dangerous medical errors—and what it needs now is a disruptive infusion of competition.

Women underrepresented in clinical trials for heart failure, acute coronary syndrome

While women are equally or overrepresented in clinical trials for hypertension, atrial fibrillation (AFib) and pulmonary arterial hypertension, they are underrepresented in clinical trials for heart failure, coronary artery disease and acute coronary syndrome, according to a new study published in the Journal of the American College of Cardiology.

Eidos Therapeutics Initiates Phase 2 Clinical Trial for AG10 Targeting Transthyretin Amyloidosis Cardiomyopathy

SAN FRANCISCO, May 3, 2018 /PRNewswire/ — Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company developing a novel oral therapy to treat transthyretin (TTR) amyloidosis (ATTR), today announced dosing of the first patient in the Phase 2 clinical trial of AG10 in patients with ATTR cardiomyopathy.